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Abstract: Here we report a case of successful fiber optic laser treatment of lymphedema in a
swollen arm post mastectomy. At the moment, this procedure has only anecdotal evidence to
justify its use, but in our experience is a feasible, minimally invasive day-stay procedure which has
been demonstrated to be safe and effective. Further nonhomogeneous case pooling and follow-up
would enable guidelines and definite surgical protocols for its use to be implemented.
Keywords: fiber optic, lymphedema, Nd:YAG, laser, mastectomy

Introduction
Fiber optic laser surgery has been successfully introduced in several medical fields,
especially in the oncological area.1–5 In angiology, intravenous laser therapy is a dedicated venous procedure which can be used to remove an occlusion in the lumen of
the saphenous system.6 Over the last 3 years, we have gained considerable confidence
in fiber optic technology, and have recently started to use this technique to assist in
drainage of interstitial fluid to prevent fibrosis in patients with breast-cancer-related
lymphedema.7 Furthermore, a previous study used gallium arsenide (GaAs) laser
therapy in postmastectomy patients, resulting in limb volume reduction and increases
in shoulder mobility and grip strength.8 Keeping the fiber optic laser positioned in a
150 µm cavity under the skin, the laser is then rotated upwards and activated to produce
a series of short radial 10–15 cm tunnels within the normal lymphatic network in the
skin, with the aim of diverting the volume of pooled interstitial fluid cephalad, redistributing the fluid in different directions by pressotherapy,9 and inducing reabsorption of
the fluid into the lymphatic vessels (Figure 1). The procedure can be performed under
local anesthesia with or without simple sedation, and with the aid of a skin cooling
system.10 Because it is an office or day-surgery procedure, it should not require any
theatre time or prolonged hospital stay.

Case report
Twelve months ago, a 77-year-old woman, who had had a partial right mastectomy
(biquadrantectomy) and lymphadenectomy for metastatic cancer, presented with progressive lymphedema of her right arm and an erysipelatous infection which was immediately
treated with an aggressive combination regimen of teicoplanin (Targosid, 200 mg;
Sanofi-Aventis, Milan, Italy) and vancomycin (Vancomicina Hikma, 250 mg; Hikma
Italia, Pavia, Italy). The patient underwent rehabilitation consisting of overnight elastic
support with regular active and passive muscle exercise during the day. The patient’s arm
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Figure 1 (A) Radial short tunnels along the right upper arm. (B and C) Nd:YAG
laser device and operating settings. (D) Introduction of the fiber optic laser through
an incision in the skin, along with the skin cooling system.

circumference measurements at presentation are reported in
Table 1. The patient signed an informed consent explaining
the laser procedure in detail and its potential complications.
She agreed to undergo laser treatment in view of progressive
hardening and stiffening of her finger, wrist, and elbow. The
procedure was performed in accordance with the tenets of
the Declaration of Helsinki. Internal review board approval
was obtained.
A 1062 nm 15 W Nd:YAG system (Evlaser®, Elettronica
Valseriana, Casnigo, Italy) was used. It was connected to a
150 µm diameter and 1 m long sterile fiber optic. Tramadol
(Unitrama, 100 mg capsules; Angelini, Rome, Italy) and
ketoprofen (Artrosilene, 160 mg/2 mL injectable solution;
Dompé, L’Aquila, Italy) were administered by an intravenous
line at the beginning of treatment, with an assistant cooling
the arm using a frozen 10 cm2 diameter plate. A bolus of 2%
lidocaine (Lidocaina 100 mg/5 mL; Angelini) was injected
to anesthetize the 2 cm2 area of skin selected to introduce
the fiber optic laser. Skin perforation was performed using
a 21-gauge plastic venous catheter bearing a stainless steel
stylet to aid introduction. Next, the stylet was withdrawn
and the fiber optic laser was introduced into the lumen and
advanced forward with its tip continuously emitting 150 J/cm2

to perforate the fibrous tissue and create a channel during
advancement along the entire length of her arm (Figure 2).
At the end of the procedure, the fiber optic tip was retrieved
via the incision in the skin and redirected subdermally
upwards into the normal lymphatic network, advanced for
a shorter length (15–20 cm) in multiple radial directions
to create shorter (15–30) tunnels where the lymph, which
had been pushed upwards, could be temporarily pooled and
then absorbed via the normal lymphatic network. The time
taken to complete the procedure was about 1.5 hours. No
stitches were required at the laser access site, and an elastic
bandage was applied for 24 hours postoperatively. At 10-day
follow-up, a decrease of arm and forearm circumference was
observed (Figure 3; Table 1). The procedure was repeated 2
weeks later in previously untreated regions of her right arm
using the same protocol to achieve further volume reduction
(Figure 3) and thereby improve her arm function. After the
second session, the patient’s range of movement at her fingers,
wrist, and elbow had improved.
Four month follow-up showed partial relapse of the
treated segments consistent with hardness and stiffness. No
further decrease in right arm circumference was observed,
but the patient did not revert to her original clinical condition and asked for a third laser procedure because of the
pain-free nature and low invasiveness of the method. After
the procedure, the patient underwent three daily 30-minute
sessions of manual lymph drainage and home pressotherapy
twice daily for a week.

Discussion
This is the first report of the feasibility and safety of a novel
procedure to reduce lymphedema using fiber optic laser to
drill new channels for lymphatic drainage. In our experience, the procedure can be repeated up to 5–10 times in 6
months, depending on the patient’s connective tissue reaction. Lymph drainage by manual massage and pressotherapy
helps the drilled tunnels to become engorged with interstitial
fluid and improves their patency, which counteracts occlusion
by exceeding the outer-inner pressure ratio. The procedure
described in this article is painless, if local anesthesia is

Table 1 Patient’s upper limb circumference measurements before and after first and second treatment
Right arm
First treatment
36 cm
First follow-up (10 days) 34 cm
Second treatment
34 cm
Second follow-up (4 months)34 cm

Left arm

Right forearm

Left forearm

Right wrist

Left wrist

30 cm
30 cm
30 cm
30 cm

33 cm
31 cm
31 cm
30 cm

26 cm
26 cm
26 cm
26 cm

22 cm
22 cm
20 cm
20 cm

19 cm
19 cm
19 cm
19 cm

Note: Partial relapse of treated segments observed after second follow-up.
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Figure 2 Introduction of a 21-gauge plastic venous catheter and subsequently of the
fiber optic laser through an incision in the skin.

used at the skin access site and the arm surface is regularly
cooled.11 Obviously, multiple longitudinal channel drilling
cannot be considered a radical management procedure for
lymphedema. Because it achieves autonomous active lymphatic drainage, regular daily mechanical or manual pressotherapy9 is required to keep the channels open and prevent
further fibrotic reactions and obstruction of continuous
lymph flow into the newly formed lumen. In our experience,
it is mandatory to prepare a functional area in the normal
dermis cephalad to the lymphedematous tissue in order to
distribute the drained lymphatic volume recovered by daily
pressotherapy through these short (15–20 cm) newly formed
channels. Even if this step may damage the normal lymphatic
network in the adjacent area,12 it is necessary in order to
facilitate uptake of fluid into normal lymphatic vessels. In

Fiber optic laser approach for lymphedematous syndrome

fact, in our experience, it is very easy to drill the fibrotic septa
that trap interstitial fluid in lymphedema by laser energy,
but these passive newly formed lumina are prone to further
fibrosis and obliteration. Therefore, our future goal will be to
seed a layer of autologous endothelial cells recovered from
short-segment phlebectomy into the newly formed channels or inject bone marrow-derived mesothelial stem cells
to form a new endothelial surface, mimicking the patency
and function of the normal lymphatic network.13 Our fiber
optic laser channel drilling approach with moderate beam
power (150 J/cm2) is very effective for rapid perforation of
fibrous strands of lymphedematous tissue, without excessive heating or burning adjacent structures. In particular,
when the fiber optic is withdrawn at the end of treatment,
the interstitial fluid becomes cooler quickly since it is forced
to diffuse into the new channels created by the laser. Active
and passive rehabilitation exercise promotes continuous
lymph flow into these structures, prolongs their patency and
viability, and may be very efficacious if antifibrotic treatment
is administered at the same time.14

Conclusion
Treatment of lymphedema using f iber optic laser is
now a promising candidate treatment for helping pressotherapy rehabilitation to improve function and quality of life
in patients affected by lymphedema.
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